Sara Elizabeth Stinson

This study investigates genetic overlaps between psychiatric disorders, cardiometabolic diseases, and brain structure to understand shared and distinct genetic pathways contributing to comorbidity.

This paper uses genetic data from psychiatric disorders to prioritize drug targets and compounds, identifying genetic support for existing medications and opportunities for drug repurposing.

The paper conducts a multi-ancestry, trans-generational GWAS meta-analysis of gestational diabetes and glycemic traits, identifying novel loci and highlighting limited pregnancy-specific genetic effects.

The paper identifies sex differences in genetic and biological factors contributing to ischaemic heart disease-depression comorbidity, finding higher genetic correlation in females and distinct risk factors by sex.

This study identifies 251 genetic variants influencing plasma proteins in Greenlandic Inuit, revealing population-specific associations with cardiometabolic disease.

This study identifies distinct genetic overlaps between Alzheimer's and Parkinson's disease and metabolic markers, revealing disease-specific pathways involving lipid metabolism and synaptic processes.

This study identifies genetic regulation of plasma proteins in children and adolescents, finding obesity- and age-dependent pQTLs and potential causal links to cardiometabolic traits.

This study identifies genetic determinants of plasma protein levels in children and adolescents using MS-based proteomics, revealing extensive genetic impacts that persist into adulthood.

The paper identifies extensive phenotypic and genetic links between systemic metabolism and brain morphology using UK Biobank data.

This study identifies 40 genetic loci associated with placental weight using GWAS in 179,025 children and parents, revealing shared and distinct genetic influences with fetal growth.